. 2017 Oct 6;15(1):642–648. doi: 10.3892/ol.2017.7147

Table V.

Drug-resistant stem cells in SUL-R Apc^−/− 1638N COL-Pr1 cells.

Stem cell marker^a	SUL-S	SUL-R	δ-SUL-S
Tumor spheroids	2.3±1.7	18.7±3.3	+7.1X^b
CD44 (FU)	2.1±0.6	14.4±1.5	+5.7X^c
CD133 (FU)	3.1±1.2	14.2±1.3	+3.6X^d
c-Myc (FU)	2.6±0.7	7.0±0.5	+1.7X^e

Mean ± standard deviation (n=3 per treatment group).

^b,c

P=0.01 compared with the SUL-S phenotype.

^d,e

P=0.02 compared with the SUL-S phenotype. Data were analyzed by Student's t-test. SUL-S, sulindac-sensitive; SUL-R, sulindac-resistant; FU, log mean fluorescence units; Apc, adenomatous polyposis coli; X, fold-change.